This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

reputable news agency

proofread

Polypill not linked to reduced cognitive decline in seniors

Polypill not linked to reduced cognitive decline in seniors

A polypill (antihypertensives and a statin) does not reduce cognitive decline but is associated with reduced functional decline for adults aged 65 years and older with cardiovascular risk factors, according to a study published online Jan. 30 in JAMA Neurology.

Jacqueline J. Bosch, Ph.D., from McMaster University and Hamilton Health Sciences in Canada, and colleagues examined whether a polypill could reduce cognitive and in 2,098 people aged 65 years or older, with but without cardiovascular disease.

Overall, 86 and 32 percent of participants had hypertension and impaired fasting plasma glucose levels, respectively. The researchers found that the mean baseline was 146.1 mm Hg and the mean low-density lipoprotein cholesterol level was 124.3 mg/dL; among those assigned to the polypill group, decreases of 5.7 mmHg and 24 mg/dL, respectively, were seen.

No significant differences were seen between the treatment groups in the number of participants who experienced substantive or dementia during a five-year follow-up. For those assigned to the polypill versus placebo or polypill plus aspirin versus double placebo, functional decline was reduced during follow-up.

"Although mean change in score for any cognitive measure was not different between groups, there was a significant difference in mean functional decline between the groups at study end for both the polypill versus placebo and the polypill plus aspirin versus placebo comparisons," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

More information: Jacqueline J. Bosch et al, Effects of a Polypill, Aspirin, and the Combination of Both on Cognitive and Functional Outcomes, JAMA Neurology (2023). DOI: 10.1001/jamaneurol.2022.5088

Journal information: Archives of Neurology

Copyright © 2023 HealthDay. All rights reserved.

Citation: Polypill not linked to reduced cognitive decline in seniors (2023, January 30) retrieved 28 March 2024 from https://medicalxpress.com/news/2023-01-polypill-linked-cognitive-decline-seniors.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Fluvoxamine does not improve time to sustained recovery in mild COVID-19

2 shares

Feedback to editors